PERCEPTIVE ADVISORS LLC

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
166 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -75%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
PERCEPTIVE ADVISORS LLC's trades of Lyra Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-13 2025-11-13
S Sale
46,114 -21.1%
230.10
US$4,096,702 		46,114 -21.1% 230.10 US$4,096,702
2025-11-13 2025-11-13
S Sale
1,778 +20.8%
328.66
US$2,155,203 		1,778 +20.8% 328.66 US$2,155,203
2025-11-13 2025-11-12
S Sale
68,211 -20.6%
368.74
US$792,831 		68,211 -20.6% 368.74 US$792,831
2025-11-13 2025-11-12
S Sale
7,862 -4.9%
4.06
US$31,915 		7,862 -4.9% 4.06 US$31,915
2025-11-13 2025-11-11
S Sale
537 -2.9%
4.31
US$2,317 		537 -2.9% 4.31 US$2,317
2025-11-13 2025-11-11
S Sale
4,783 -2.9%
4.31
US$20,637 		4,783 -2.9% 4.31 US$20,637
2025-11-10 2025-11-10
S Sale
1,869 -9.1%
4.54
US$8,485 		1,869 -9.1% 4.54 US$8,485
2025-11-10 2025-11-10
S Sale
16,633 -9.1%
4.54
US$75,510 		16,633 -9.1% 4.54 US$75,510
2025-11-10 2025-11-07
S Sale
1,993 -8.8%
4.75
US$9,460 		1,993 -8.8% 4.75 US$9,460
2025-11-10 2025-11-07
S Sale
17,746 -8.9%
4.75
US$84,235 		17,746 -8.9% 4.75 US$84,235
2025-11-10 2025-11-06
S Sale
3,247 -12.6%
5.18
US$16,819 		3,247 -12.6% 5.18 US$16,819
2025-11-10 2025-11-06
S Sale
28,902 -12.6%
5.18
US$149,709 		28,902 -12.6% 5.18 US$149,709
2025-08-05 2025-08-01
B Purchase
700,000 +15.2%
2.75
US$1,925,000 		700,000 +15.2% 2.75 US$1,925,000
2025-05-01 2025-05-01
S Sale
298,886 -8.8%
1.34
US$400,507 		298,886 -8.8% 1.34 US$400,507
2025-05-01 2025-04-30
S Sale
437,881 -11.4%
1.41
US$617,412 		437,881 -11.4% 1.41 US$617,412
2025-04-29 2025-04-29
S Sale
250,000 -6.1%
1.41
US$352,500 		250,000 -6.1% 1.41 US$352,500
2025-04-29 2025-04-28
S Sale
215,283 -5.0%
1.56
US$335,841 		215,283 -5.0% 1.56 US$335,841
2025-04-29 2025-04-25
S Sale
1,054,669 -19.7%
1.95
US$2,056,605 		1,054,669 -19.7% 1.95 US$2,056,605
2025-04-07 2025-04-03
S Sale
3,400,000 -36.7%
1.42
US$4,828,000 		3,400,000 -36.7% 1.42 US$4,828,000
2025-02-21 2025-02-19
B Purchase
5,000,000 +73.2%
4.03
US$20,150,000 		5,000,000 +73.2% 4.03 US$20,150,000
2024-08-14 2024-08-12
B Purchase
1,250,000 +11.1%
4.00
US$5,000,000 		1,250,000 +11.1% 4.00 US$5,000,000
2024-04-15 2024-04-11
B Purchase
2,353,000 +78.2%
8.50
US$20,000,500 		2,353,000 +78.2% 8.50 US$20,000,500
2024-04-08 2024-04-05
B Purchase
37,712 +0.4%
4.74
US$178,755 		37,712 +0.4% 4.74 US$178,755
2024-04-08 2024-04-04
B Purchase
140,281 +1.5%
4.67
US$655,112 		140,281 +1.5% 4.67 US$655,112
2024-04-03 2024-04-03
B Purchase
309,847 +3.5%
4.09
US$1,267,274 		309,847 +3.5% 4.09 US$1,267,274
2024-04-03 2024-04-02
B Purchase
186,051 +2.2%
3.44
US$640,015 		186,051 +2.2% 3.44 US$640,015
2024-04-03 2024-04-01
B Purchase
8,374 +0.1%
3.25
US$27,216 		8,374 +0.1% 3.25 US$27,216
2024-02-05 2024-02-01
B Purchase
2,481,350 +103.7%
12.09
US$29,999,522 		2,481,350 +103.7% 12.09 US$29,999,522
2024-01-12 2024-01-11
B Purchase
3,410,713 +99.6%
5.53
US$18,861,243 		3,410,713 +99.6% 5.53 US$18,861,243
2023-12-29 2023-12-29
US LeonaBio Inc (ATHA)
B Purchase
163,954 +3.1%
2.38
US$390,211 		163,954 +3.1% 2.38 US$390,211
2023-12-29 2023-12-29
B Purchase
115,774 +1.7%
7.24
US$838,204 		115,774 +1.7% 7.24 US$838,204
2023-12-29 2023-12-28
US LeonaBio Inc (ATHA)
B Purchase
409,598 +8.5%
2.44
US$999,419 		409,598 +8.5% 2.44 US$999,419
2023-12-29 2023-12-28
B Purchase
126,116 +1.8%
7.08
US$892,901 		126,116 +1.8% 7.08 US$892,901
2023-12-29 2023-12-27
US LeonaBio Inc (ATHA)
B Purchase
32,134 +0.7%
2.28
US$73,266 		32,134 +0.7% 2.28 US$73,266
2023-12-29 2023-12-27
B Purchase
79,726 +1.2%
7.20
US$574,027 		79,726 +1.2% 7.20 US$574,027
2023-12-26 2023-12-26
B Purchase
54,652 +0.8%
6.49
US$354,691 		54,652 +0.8% 6.49 US$354,691
2023-12-26 2023-12-22
B Purchase
250,000 +3.9%
6.67
US$1,667,500 		250,000 +3.9% 6.67 US$1,667,500
2023-12-26 2023-12-21
B Purchase
200,000 +3.2%
6.17
US$1,234,000 		200,000 +3.2% 6.17 US$1,234,000
2023-12-22 2023-12-21
B Purchase
740,000 +44.8%
6.20
US$4,588,000 		740,000 +44.8% 6.20 US$4,588,000
2023-12-19 2023-12-19
B Purchase
277,008 +4.6%
5.36
US$1,484,763 		277,008 +4.6% 5.36 US$1,484,763
2023-12-19 2023-12-18
B Purchase
456,923 +8.2%
5.41
US$2,471,953 		456,923 +8.2% 5.41 US$2,471,953
2023-12-19 2023-12-15
B Purchase
500,000 +9.9%
5.97
US$2,985,000 		500,000 +9.9% 5.97 US$2,985,000
2023-11-14 2023-11-14
B Purchase
333,333 +inf%
15.00
US$4,999,995 		333,333 +inf% 15.00 US$4,999,995
2023-11-14 2023-11-14
B Purchase
333,333 +12.9%
15.00
US$4,999,995 		333,333 +12.9% 15.00 US$4,999,995
2023-10-18 2023-10-18
S Sale
306,499 -3.4%
1.74
US$533,308 		306,499 -3.4% 1.74 US$533,308